Cargando…

A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States

Macrolide resistance was found in 39.5% of 3626 nonduplicate Streptococcus pneumoniae isolates from adult ambulatory and inpatient settings at 329 US hospitals (2018–2019). Macrolide resistance was significantly higher for respiratory vs blood isolates and ambulatory vs inpatient settings. Despite g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Vikas, Yu, Kalvin C, Schranz, Jennifer, Gelone, Steven P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266646/ https://www.ncbi.nlm.nih.gov/pubmed/34250183 http://dx.doi.org/10.1093/ofid/ofab063

Ejemplares similares

1440. Prevalence and Regional Variation of in ESBLs and CRE Enterobacteriaceae (ENT) among Adult, Hospitalized Patients with ENT on a Urine Culture: A Multicenter Evaluation
por: Lodise, Thomas, et al.
Publicado: (2019)

1485. Trends in Important-Resistant Gram-Negative (GN) and Gram-Positive (GP) Urine Bacterial Pathogens in Hospitalized Patients in the United States: A Multicenter Evaluation from 2013 to 2018
por: Lodise, Thomas, et al.
Publicado: (2019)

A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011–2020
por: Dunne, Michael W., et al.
Publicado: (2022)

Trends in Streptococcus pneumoniae Antimicrobial Resistance in US Children: A Multicenter Evaluation
por: Mohanty, Salini, et al.
Publicado: (2023)

Clinical features and seasonal variations in the prevalence of macrolide‐resistant Mycoplasma pneumoniae
por: Akashi, Yusaku, et al.
Publicado: (2018)

A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Streptococcus pneumoniae Isolates From Adults in the United States
por: Mohanty, Salini, et al.
Publicado: (2022)

Macrolide-Resistant Mycoplasma pneumoniae, United States
por: Zheng, Xiaotian, et al.
Publicado: (2015)

1699. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

684. Cardiac Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP) Treated with Lefamulin (LEF) or Moxifloxacin (MOX): Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results
por: Darpo, Borje, et al.
Publicado: (2019)

171. A Multicenter Analysis of Inpatient Antibiotic Use During the 2015-2019 Influenza Season in the US: Untapped Opportunities for Antimicrobial Stewardship
por: Amiche, Amine, et al.
Publicado: (2021)

Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals
por: Lodise, Thomas P., et al.
Publicado: (2020)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
por: Domon, Hisanori, et al.
Publicado: (2023)

Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
por: Lee, Eun, et al.
Publicado: (2017)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results
por: Lewis, James H, et al.
Publicado: (2019)

Macrolide Resistance in Streptococcus pneumoniae
por: Schroeder, Max R., et al.
Publicado: (2016)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study
por: Choi, Yun Jung, et al.
Publicado: (2022)

187. Regional Distribution of Antimicrobial Resistance Among Outpatient Urine e. Coli Isolates in US Females ≥12 Years of age: a Multicenter Evaluation in 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

Emergence of Macrolide-Resistant Mycoplasma pneumoniae during an Outbreak in a Primary School: Clinical Characterization of Hospitalized Children
por: Hubert, Daniel, et al.
Publicado: (2021)

398. Multicenter Evaluation of Outcomes of SARS-CoV-2 Positive Patients Treated at Rural vs Urban Hospitals in the United States
por: Bauer, Karri A, et al.
Publicado: (2021)

1850. Association between social vulnerability and Streptococcus pneumoniae antimicrobial resistance in US adults
por: Mohanty, Salini, et al.
Publicado: (2023)

703. In Vitro Activity of Lefamulin Against Bacterial Pathogens Causing Community-Acquired Bacterial Pneumonia (CABP): SENTRY Surveillance 2017–2018 Results From the United States (US)
por: Sader, Helio S, et al.
Publicado: (2019)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Seo, Young Ho, et al.
Publicado: (2014)

Streptococcal throat: Therapeutic options and macrolide resistance
por: Al-Hamad, Arif M.
Publicado: (2015)

Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States
por: Getman, Damon, et al.
Publicado: (2016)

A multicenter analysis of inpatient antibiotic use during the 2015–2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship
por: Yu, Kalvin C., et al.
Publicado: (2022)

Resistance of Streptococcus Pneumoniae to Macrolides in Iran
por: Shokouhi, Shervin, et al.
Publicado: (2019)

Macrolides as Empiric Therapy for Outpatients With Pneumonia
por: Musher, Daniel M
Publicado: (2021)

176. Antibiotic Resistance Patterns, Seasonality, and Correlation with the Influenza Season in the United States: A Multicenter Evaluation Reveals Surprising Association Between Influenza Season and Gram Negative Pathogens
por: Amiche, Amine, et al.
Publicado: (2021)

2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 2 Phase 3 Study
por: Schranz, Jennifer, et al.
Publicado: (2019)

664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes
por: Alexander, Elizabeth, et al.
Publicado: (2019)

A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19
por: Puzniak, Laura, et al.
Publicado: (2021)

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Ha, Seok Gyun, et al.
Publicado: (2018)

Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China
por: Cao, B., et al.
Publicado: (2010)

Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain
por: Maldonado-Barrueco, Alfredo, et al.
Publicado: (2023)

Antibiotic Resistance Patterns and Association With the Influenza Season in the United States: A Multicenter Evaluation Reveals Surprising Associations Between Influenza Season and Resistance in Gram-Negative Pathogens
por: Gupta, Vikas, et al.
Publicado: (2022)

2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results
por: Schranz, Jennifer, et al.
Publicado: (2019)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3qltte0etck1737dvtisfk7260